ORMP
Oramed Pharmaceuticals Inc.
4.61
2 x 3.35
2 x 5.49
bid
ask
-
0.20
4.16%
2 @ 07:45 AM
4.62 +0.01 (0.22%)
| Ytd | 61.75% | |
| 1y | 119.52% |
4.25
day range
4.75
1.98
52 week range
5.19
| Open | 4.75 | Prev Close | 4.81 | Low | 4.25 | High | 4.75 | Mkt Cap | 188.67M |
| Vol | 1.02M | Avg Vol | 280.69K | EPS | 2.60 | P/E | 1.77 | Forward P/E | -29.75 |
| Beta | 1.77 | Short Ratio | 2.60 | Inst. Own | 17.52% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-14 | 50-d Avg | 4.08 | 200-d Avg | 3.26 | 1yr Est | 3.25 |
| Income Statement | |||
| Operating Expenses | 3.66M | ||
| Research and Development Expense | 1.59M | ||
| Selling, General and Administrative Expense | 2.07M | ||
| Operating Income | -3.66M | ||
| Income Tax Expense | 11.13M | ||
| Net Income | 38.31M | ||
| Net Income Common Stock | 38.31M | ||
| Net Income Common Stock (USD) | 38.31M | ||
| Consolidated Income | 38.31M | ||
| Earnings per Basic Share | 0.94 | ||
| Earnings per Basic Share (USD) | 0.94 | ||
| Earnings per Diluted Share | 0.91 | ||
| Dividends per Basic Common Share | 0.25 | ||
| Earning Before Interest & Taxes (EBIT) | 49.44M | ||
| Earning Before Interest & Taxes (USD) | 49.44M | ||
| Weighted Average Shares | 40.77M | ||
| Weighted Average Shares Diluted | 41.97M | ||
| Balance Sheet | |||
| Cash and Equivalents | 13.20M | ||
| Cash and Equivalents (USD) | 13.20M | ||
| Investments | 250.12M | ||
| Investments Current | 52.64M | ||
| Investments Non-Current | 197.49M | ||
| Current Assets | 68.15M | ||
| Property, Plant & Equipment Net | 3.17M | ||
| Total Assets | 268.85M | ||
| Debt Current | 268.00K | ||
| Total Debt | 761.00K | ||
| Current Liabilities | 10.56M | ||
| Debt Non-Current | 493.00K | ||
| Total Liabilities | 30.57M | ||
| Accumulated Retained Earnings (Deficit) | -85.12M | ||
| Shareholders Equity | 238.28M | ||
| Shareholders Equity (USD) | 238.28M | ||
| Assets Non-Current | 200.70M | ||
| Total Debt (USD) | 761.00K | ||
| Deferred Revenue | 3.00M | ||
| Liabilities Non-Current | 20.01M | ||
| Trade and Non-Trade Payables | 8.52M | ||
| Tax Liabilities | 17.75M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 30.00K | ||
| Net Cash Flow from Financing | -10.36M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -32.74M | ||
| Capital Expenditure | -5.00K | ||
| Net Cash Flow - Business Acquisitions and Disposals | -11.92M | ||
| Payment of Dividends & Other Cash Distributions | -10.36M | ||
| Net Cash Flow from Investing | -19.49M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -7.56M | ||
| Net Cash Flow from Operations | -2.91M | ||
| Effect of Exchange Rate Changes on Cash | 22.00K | ||
| Share Based Compensation | 1.74M | ||